Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)

Marcelo C. Pasquini, MDMS, Frederick L. Locke, MD, Alex F. Herrera, MD, Tanya Siddiqi, MD, Armin Ghobadi, MD, Krishna V Komanduri, MD, Zhen-Huan Hu, MPH, Hua Dong, PhD, Peiman Hematti, MD, Sarah Nikiforow, MD PhD, Patricia Steinert, PhD, Anna Purdum, PharmD,MS, Mary M. Horowitz, Michelle Hooper, Jun Kawashima, MD, Caron A. Jacobson, MD

Blood (2019) 134 (Supplement_1): 764.

https://doi.org/10.1182/blood-2019-124750

Published: 2019

Journal Articles

Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry

Samantha Jaglowski, MD, Zhen-Huan Hu, MPH, Yiyun Zhang, PhD, Manali Kamdar, MD, Monalisa Ghosh, Premal Lulla, MBBS, Joshua Sasine, MD PhD, Miguel-Angel Perales, MD, Peiman Hematti, MD, Sarah Nikiforow, MD PhD, Patricia Steinert, PhD, Margit Jeschke, PhD, Lan Yi, PhD, Raghav Chawla, MD PhD, Lida Pacaud, Mary M. Horowitz, Eric Bleickardt, MD, Marcelo C. Pasquini, MDMS

Blood (2019) 134 (Supplement_1): 766.

https://doi.org/10.1182/blood-2019-130983

Published: 2019

Journal Articles

Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)

Binod Dhakal, MBBS, Muhammad Umair Mushtaq, MD, Ashley Cunningham, MD, Athanasios Papadas, MD, Adam Pagenkopf, BS, Joshua Wiesner, Catherine Leith, MBBChir, Peiman Hematti, MD, Parameswaran Hari, MBBS, MD, Natalie Scott Callander, MD, Fotis Asimakopoulos, PhDMBBChir,

Blood (2019) 134 (Supplement_1): 3088.

https://doi.org/10.1182/blood-2019-127565

Published: 2019

Journal Articles

Versican Proteolytic Fragments (Matrikines) Regulate the Intratumoral Dendritic Cell Milieu In Vivo: Implications for in Situ Tumor Vaccination

Athanasios Papadas, MD, Evan Flietner, BS, Zachary Morrow, BS, Joshua Wiesner, Alexander Cicala, Adam Pagenkopf, BS, Chelsea L. Hope, PhD, Adhithi Rajagopalan, BS, Zhi Wen, PhD, Philip Emmerich, Dustin Deming, Shigeki Miyamoto, PhD, Peiman Hematti, MD, Natalie Scott Callander, MD, Alexander Rakhmilevich, Mario Otto, MD PhD, Christian M. Capitini, MD, Jing Zhang, PhD, Fotis Asimakopoulos, PhDMBBChir,

Blood (2019) 134 (Supplement_1): 1210.

https://doi.org/10.1182/blood-2019-131582

Published: 2019

Journal Articles

Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World Experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and Cellular Therapy (CT) Registry

Blood (2019) 134 (Supplement_1): 2619.

https://doi.org/10.1182/blood-2019-129279

Published: 2019

Journal Articles

Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Christopher D'Angelo, MD, Sailendharan Sudakaran, PhD, Peiman Hematti, MD, Fotis Asimakopoulos, PhDMBBChir,, Craig Augustine, MBA, Nasia Safdar, MD PhD, Natalie Scott Callander, MD

Blood (2019) 134 (Supplement_1): 4653.

https://doi.org/10.1182/blood-2019-123530

Published: 2019

Journal Articles

A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies

Christopher R. D'Angelo, MD, Aric C. Hall, MD, Kyungmann Kim, PhD, Ryan J. Mattison, MD, Walter L. Longo, MD, Peiman Hematti, MD, Natalie Scott Callander, MD, Mark Juckett, MD

Blood (2018) 132 (Supplement 1): 2107.

https://doi.org/10.1182/blood-2018-99-112670

Published: 2018

Journal Articles

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Blood (2018) 132 (Supplement 1): 1015.

https://doi.org/10.1182/blood-2018-99-110814

Published: 2018

Journal Articles

GATA/Heme Multi-Omics Reveals a Trace Metal-Dependent Erythrocyte Developmental Mechanism

Nobuyuki Tanimura, PhD, Ruiqi Liao, PhD, Gary M Wilson, Matthew R Dent, Miao Cao, Judith N Burstyn, PhD, Peiman Hematti, MD, Xin Liu, PhD, Yuannyu Zhang, PhD, Ye Zheng, Sunduz Keles, PhD, Jian Xu, PhD, Joshua J Coon, PhD, Emery H Bresnick, PhD

Blood (2018) 132 (Supplement 1): 500.

https://doi.org/10.1182/blood-2018-99-115324

Published: 2018

Journal Articles

The Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Transplantation

Claudio G Brunstein, MD PhD, Marcelo C. Pasquini, MDMS, Soyoung Kim, Mingwei Fei, MS, Andrew Artz, MD, Minoo Battiwalla, MD, Nelli Bejanyan, MD, Robert Peter Gale, MD ScD, PhD, Peiman Hematti, MD, Oscar Boutros Lahoud, MD, Marcos De Lima, MD, Ran Reshef, MD, Seth J Rotz, MD, Bipin N. Savani, MD, Harry C. Schouten, MD, Shin Mineishi, MD, John Rogosheske, PharmD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 3292.

https://doi.org/10.1182/blood.V130.Suppl_1.3292.3292

Published: 2017

Journal Articles

Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT)

Adam Pagenkopf, Binod Dhakal, MBBS, Chelsea L. Hope, PhD, Athanasios Papadas, MD, Michael G Johnson, PhD, Bradley Nagel, Elena Kurudza, Samik Partha, Bianca Ruffolo, Catherine Leith, MBBChir, Shigeki Miyamoto, PhD, Peiman Hematti, MD, Parameswaran Hari, MD MRCP, MS, Natalie Scott Callander, MD, Fotios Asimakopoulos, PhDMBBChir,

Blood (2017) 130 (Supplement 1): 1756.

https://doi.org/10.1182/blood.V130.Suppl_1.1756.1756

Published: 2017

Journal Articles

Utilization of Leftover Autologous Peripheral Blood Stem Cells (PBSCs) in Patients with Multiple Myeloma (MM)

Natalie S Callander, MD, Walter L. Longo, MD, Mark B. Juckett, MD, Vaishalee P. Kenkre, MD, Peiman Hematti, MD, Janelle McMannes, Rebecca K Evans, Linda A Eckstein, MSN,NP, Blythe Gage, NP

Blood (2014) 124 (21): 2654.

https://doi.org/10.1182/blood.V124.21.2654.2654

Published: 2014

Journal Articles

The Utility Of Monitoring Chimerism: More Predictive For Nonablative Regimens?

Lyndsey Runaas, MD, Walter L. Longo, MD, Mark Juckett, MD, Wayne Borcherding, BS, Peiman Hematti, MD, Rachel J Cook, MD, MS

Blood (2013) 122 (21): 5490.

https://doi.org/10.1182/blood.V122.21.5490.5490

Published: 2013

Journal Articles

Recovery Of Natural Killer Cells and Monocyte Subsets Following Autologous Peripheral Blood Stem Cell Transplantation Predicts Longer Progression Free Survival Among Multiple Myeloma Patients

Natalie S Callander, MD, Paul J Rathouz, PhD, Fotis Asimakopoulos, MBBChir, PhD, Mark B Juckett, MD, Christopher L Coe, PhD, Dagna Sheerar, BS, Karen Ersland, PhD, Peiman Hematti, MD, Erin S Costanzo, PhD

Blood (2013) 122 (21): 2126.

https://doi.org/10.1182/blood.V122.21.2126.2126

Published: 2013

Journal Articles

Molecular Pathways That Determine the Activation State of Macrophages within the Myeloma Niche

Chelsea Hope, Ellen Hebron, Jaehyup Kim, MD, Jeff Jensen, Claire Flanagan, Neehar Bhatia, Catherine Leith, MBBChir, Ioanna Maroulakou, PhD, Constantine S. Mitsiades, MD, PhD, Shigeki Miyamoto, PhD, Natalie Callander, MD, Peiman Hematti, MD, Fotis Asimakopoulos, MBBChir, PhD

Blood (2012) 120 (21): 443.

https://doi.org/10.1182/blood.V120.21.443.443

Published: 2012

Journal Articles

Optical Mapping of the Myeloma Cancer Genome to Elucidate Mechanisms of Acquired Resistance to Proteasome Inhibitors.

Aditya Gupta, Jaehyup Kim, MD, Chelsea Hope, Jeff Jensen, Natalie Callander, MD, Peiman Hematti, MD, Emery H Bresnick, PhD, David C Schwartz, PhD, Fotis Asimakopoulos, MBBChir, PhD

Blood (2012) 120 (21): 2444.

https://doi.org/10.1182/blood.V120.21.2444.2444

Published: 2012

Journal Articles

HLA DR15 Antigen Status Does Not Impact Graft-Versus-Host Disease or Disease-Free Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

Blood (2011) 118 (21): 3094.

https://doi.org/10.1182/blood.V118.21.3094.3094

Published: 2011

Journal Articles

Mesenchymal Stem Cells Convert Human Macrophages to a Novel Type of Alternatively Activated Macrophages.

Jaehyup Kim, MD, Peiman Hematti, MD

Blood (2009) 114 (22): 3632.

https://doi.org/10.1182/blood.V114.22.3632.3632

Published: 2009

Journal Articles

Long-Term Polyclonal and Stable Gene Transfer into Rhesus Repopulating Hematopoietic Stem Cells Using a Simian Immunodeficiency Virus-Based Lentiviral Vector System.

Yoo-Jin Kim, MD, Nadia L. Hussein, Peiman Hematti, MD, Bum-Kee Hong, MD, Boris Calmels, PhD, Robert E. Donahue, DVM, Hideki Hanawa, MD, Arthur W. Nienhuis, MD, Cynthia E. Dunbar, MD

Blood (2006) 108 (11): 3259.

https://doi.org/10.1182/blood.V108.11.3259.3259

Published: 2006

Journal Articles

Analysis of Clonal Contributions to T Lymphoid and Myeloid Lineages during Early Hematopoiesis Following Autologous Transplantation in the Rhesus Macaque.

Rima L. Adler, BA, Peiman Hematti, MD, Boris Calmels, PhD, Cole J. Ferguson, BA, Keyvan Keyvanfar, BS, Colin Wu, PhD, Dean Follmann, PhD, Cynthia E. Dunbar, MD

Blood (2004) 104 (11): 2672.

https://doi.org/10.1182/blood.V104.11.2672.2672

Published: 2004

NARROW

Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)

Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry

Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)

Versican Proteolytic Fragments (Matrikines) Regulate the Intratumoral Dendritic Cell Milieu In Vivo: Implications for in Situ Tumor Vaccination

Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World Experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and Cellular Therapy (CT) Registry

Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

GATA/Heme Multi-Omics Reveals a Trace Metal-Dependent Erythrocyte Developmental Mechanism

The Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Transplantation

Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT)

Utilization of Leftover Autologous Peripheral Blood Stem Cells (PBSCs) in Patients with Multiple Myeloma (MM)

The Utility Of Monitoring Chimerism: More Predictive For Nonablative Regimens?

Recovery Of Natural Killer Cells and Monocyte Subsets Following Autologous Peripheral Blood Stem Cell Transplantation Predicts Longer Progression Free Survival Among Multiple Myeloma Patients

Molecular Pathways That Determine the Activation State of Macrophages within the Myeloma Niche

Optical Mapping of the Myeloma Cancer Genome to Elucidate Mechanisms of Acquired Resistance to Proteasome Inhibitors.

HLA DR15 Antigen Status Does Not Impact Graft-Versus-Host Disease or Disease-Free Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

Mesenchymal Stem Cells Convert Human Macrophages to a Novel Type of Alternatively Activated Macrophages.

Long-Term Polyclonal and Stable Gene Transfer into Rhesus Repopulating Hematopoietic Stem Cells Using a Simian Immunodeficiency Virus-Based Lentiviral Vector System.

Analysis of Clonal Contributions to T Lymphoid and Myeloid Lineages during Early Hematopoiesis Following Autologous Transplantation in the Rhesus Macaque.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only